| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012258043 |
| P356 | DOI | 10.1186/S12948-015-0023-Y |
| P932 | PMC publication ID | 4524393 |
| P698 | PubMed publication ID | 26244040 |
| P5875 | ResearchGate publication ID | 280730114 |
| P50 | author | Filippo Fassio | Q61089734 |
| Enrico Heffler | Q51721519 | ||
| Giorgio Walter Canonica | Q56380976 | ||
| P2093 | author name string | Marco Caminati | |
| Ilaria Massaro | |||
| Oliviero Rossi | |||
| Cristina Quecchia | |||
| P2860 | cites work | Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective | Q79920693 |
| Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey | Q80505683 | ||
| Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study | Q86481318 | ||
| A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis | Q95569339 | ||
| Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis. | Q45969804 | ||
| A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis | Q46795844 | ||
| Impact of allergic rhinitis symptoms on quality of life in primary care | Q48209846 | ||
| Allergic rhinitis and the common cold--high cost to society | Q48380017 | ||
| Relationship of nasal congestion with sleep, mood, and productivity | Q48472974 | ||
| Uncontrolled allergic rhinitis during treatment and its impact on quality of life: A cluster randomized trial | Q48802333 | ||
| Allergic rhinitis is a risk factor for traffic safety | Q50051731 | ||
| Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey. | Q51493189 | ||
| Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. | Q51912843 | ||
| Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. | Q53459403 | ||
| The diagnosis and management of rhinitis: an updated practice parameter | Q28288874 | ||
| EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy | Q30394524 | ||
| World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) | Q34589248 | ||
| BSACI guidelines for the management of allergic and non-allergic rhinitis | Q34725718 | ||
| Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray | Q36087980 | ||
| Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction | Q36826600 | ||
| Allergic rhinitis: the impact of discordant perspectives of patient and physician on treatment decisions | Q36934155 | ||
| The voice of the patients: allergic rhinitis is not a trivial disease | Q37054829 | ||
| Airway dysfunction in elite athletes--an occupational lung disease? | Q38151793 | ||
| MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety | Q39244052 | ||
| Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis | Q39282024 | ||
| Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis | Q42163736 | ||
| Integrated care pathways for airway diseases (AIRWAYS-ICPs). | Q42210687 | ||
| Burden of allergic rhinitis: results from the Pediatric Allergies in America survey | Q43614653 | ||
| Rhinitis and onset of asthma: a longitudinal population-based study | Q43995099 | ||
| Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis | Q44800324 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 17 | |
| P577 | publication date | 2015-08-04 | |
| P1433 | published in | Clinical and Molecular Allergy | Q15765512 |
| P1476 | title | Escaping the trap of allergic rhinitis | |
| P478 | volume | 13 |
| Q26768647 | Allergic Rhinitis and Chronic Daily Headaches: Is There a Link? |
| Q38842283 | Comparison of allergenic extracts from different origins: the value of the FDA's bioequivalent allergy unit (BAU). |
| Q55481967 | House dust mite-related respiratory allergies and probiotics: a narrative review. |
Search more.